Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura

The Journal of Pediatrics - Tập 143 - Trang 670-673 - 2003
Kristi L Bengtson1, Michael A Skinner1, Russell E Ware1
1From the Division of Pediatric Hematology/Oncology, Department of Pediatrics, and the Division of Pediatric Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

The Journal of Pediatrics

Tập 143

670-673

Thông tin tác giả